Cite
HARVARD Citation
Longo Muñoz, F. et al. (n.d.). P-335FOLFIRINOX versus Nab-paclitaxel plus gemcitabine in the first-line chemotherapy for patients with advanced pancreatic ductal adenocarcinoma: a multivariate analysis of prognostic factors in a national cohort (Comunica-TTD working group). Annals of oncology. p. . [Online].